ALVELTAMIG
UNII JS9TS9U9N4

Substance Identification & Data

This profile provides standardized clinical and technical data for Alveltamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JS9TS9U9N4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3062244-97-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

JS9TS9U9N4

CAS Registry Number

3062244-97-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ALVELTAMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13944

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alveltamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALVELTAMIG

Common Names & Synonyms

ALVELTAMIG [INN]

IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_(SCFVHK-15MER-SCFVHL-G1(H-CH2-CH3)), ANTI-(HOMO SAPIENS DLL3 (DELTA-LIKE LIGAND 3, DELTA LIKE CANONICAL NOTCH LIGAND 3)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFIC, TRIVALENT

IMMUNOGLOBULIN G1, TRISPECIFIC, ANTI-(HUMAN NOTCH LIGAND DLL3) (HUMAN-MOUSE MONOCLONAL ANTI-DLL3-(D139A) SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)3-VL) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL ANTI-CD3-(SP34) SINGLE-CHAIN VARIABLE FRAGMENT VH-(GKPGS)4-VL) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (5-SERINE,19-PHENYLALANINE,20-GLUTAMIC ACID,116-SERINE,139-CYSTEINE,141-LYSINE,142-LYSINE,184-LYSINE) (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), (515->227'),(518->230'),(632->350')-TRIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (215-ARGININE,235-PHENYLALANINE,236-GLUTAMIC ACID,332-SERINE,350-CYSTEINE,371-GLUTAMIC ACID,410-APSARTIC ACID,440-GLUTAMIC ACID) ANTI-(HUMAN NOTCH LIGAND DLL3) (HUMAN-MUS MUSCULUS MONOCLONAL ANTI-DLL3-(1D4) .GAMMA.1-CHAIN), (221'->219'')-DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL ANTI-DLL3-(1D4) .KAPPA.-CHAIN

External Clinical & Regulatory Resources

Previous UNIIJS9NP12Y1Y

Next UNIIJS9WH65CUE